Faridi Farnaz, Ponnusamy Kanagaraju, Quagliano-Lo Coco Isabell, Chen-Wichmann Linping, Grez Manuel, Henschler Reinhard, Wichmann Christian
Department of Transfusion Medicine, Cell Therapeutics and Hemostasis, Ludwig-Maximilian University Hospital Munich, Germany.
Department of Transfusion Medicine, Cell Therapeutics and Hemostasis, Ludwig-Maximilian University Hospital Munich, Germany ; Institute of Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Germany.
Front Genet. 2013 Nov 28;4:254. doi: 10.3389/fgene.2013.00254.
Transcription is a tightly regulated process ensuring the proper expression of numerous genes regulating all aspects of cellular behavior. Transcription factors regulate multiple genes including other transcription factors that together control a highly complex gene network. The transcriptional machinery can be "hijacked" by oncogenic transcription factors, thereby leading to malignant cell transformation. Oncogenic transcription factors manipulate a variety of epigenetic control mechanisms to fulfill gene regulatory and cell transforming functions. These factors assemble epigenetic regulators at target gene promoter sequences, thereby disturbing physiological gene expression patterns. Retroviral vector technology and the availability of "healthy" human hematopoietic CD34+ progenitor cells enable the generation of pre-leukemic cell models for the analysis of aberrant human hematopoietic progenitor cell expansion mediated by leukemogenic transcription factors. This review summarizes recent findings regarding the mechanism by which leukemogenic gene products control human hematopoietic CD34+ progenitor cell expansion by disrupting the normal epigenetic program.
转录是一个受到严格调控的过程,可确保众多调节细胞行为各个方面的基因得到正确表达。转录因子调控多个基因,包括其他转录因子,它们共同控制着一个高度复杂的基因网络。转录机制可能会被致癌转录因子 “劫持”,从而导致恶性细胞转化。致癌转录因子操纵多种表观遗传控制机制来实现基因调控和细胞转化功能。这些因子在靶基因启动子序列处组装表观遗传调节因子,从而扰乱生理基因表达模式。逆转录病毒载体技术以及 “健康” 人类造血CD34+祖细胞的可得性,使得能够生成白血病前期细胞模型,用于分析由白血病转录因子介导的异常人类造血祖细胞扩增。本综述总结了关于致癌基因产物通过破坏正常表观遗传程序来控制人类造血CD34+祖细胞扩增机制的最新研究发现。